Table 1.

Survival time and percentage-increased life span (ILS%) of glioma-bearing nude mice treated with targeting epirubicin plus celecoxib liposomes

Treatment groups	Survival (days)			ILS%
	Range	Mean ± SD	Median	Mean	Median
Physiological saline	13–25	19.50±4.37	19	NA	NA
Free epirubicin	13–26	20.25±4.39	21	3.85	10.53
Epirubicin liposomes	15–30	24.00±5.75	25	23.08	31.58
Epirubicin plus celecoxib liposomes	14–33	26.38±6.67	26	35.26	36.84
Targeting epirubicin plus celecoxib liposomes	15–36	28.75±7.30a,b	30	47.43	57.89

Notes: P<0.05;

^avs physiological saline;

^bvs free epirubicin; n=8.

Abbreviations: NA, not applicable; SD, standard deviation.